Study of a patient guide for young people at risk of psychosis
Part of Mental health clinical trials.
This study tests how a “patient guide” (Patientheque) may help young people who are either having a first psychosis episode or showing early warning signs. It aims to support care decisions and reduce stress by improving understanding and follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your legal guardian) are willing to give consent to join the study
- You are between 15 and 30 years old and receiving psychiatric care in Brest for a first psychosis episode, or you’re newly identified as “at risk”
- Your situation is one of these early warning groups, such as GRD, APS, or BLIPS, or you meet a “psychosis threshold” on the CAARMS test
- You do not have a history of psychosis lasting more than 1 year
- Your CAARMS test does NOT show you are “not at risk” for psychosis
- You do not have a known neurological problem or another medical issue that could explain the symptoms
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how psychosis symptoms and development change over time in children and teens. It may help doctors better understand different patterns of illness and how to support young people with these disorders.
This study looks at how the brain processes what we see and hear in people experiencing early signs of psychosis, and compares those results with healthy people. It aims to find early markers that could help improve care.
This study looks at how the brain processes information in people with early psychosis compared to healthy controls. It may help improve understanding and treatment of psychosis.
This trial tests whether a personalized care plan improves day-to-day functioning for people in the early stages of psychosis. It aims to see if adding structured support after a recent diagnosis can help you function better.
This study explores how young people who are at high risk for psychosis or have had a first episode experience mindfulness. It uses interviews to understand their personal experience, which could help improve future treatments.
This study is testing a new French version of a questionnaire (SPI-CY) that helps doctors better understand early signs of psychosis in teenagers. If you are 12 to 17 and already being checked for these signs, you may be able to help improve the tool.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.